Your browser doesn't support javascript.
loading
Peroxisome Proliferator-Activated Receptor-δ Deficiency in Microglia Results in Exacerbated Axonal Injury and Tissue Loss in Experimental Autoimmune Encephalomyelitis.
Doroshenko, Ellinore R; Drohomyrecky, Paulina C; Gower, Annette; Whetstone, Heather; Cahill, Lindsay S; Ganguly, Milan; Spring, Shoshana; Yi, Tae Joon; Sled, John G; Dunn, Shannon E.
Afiliação
  • Doroshenko ER; Department of Immunology, University of Toronto, Toronto, ON, Canada.
  • Drohomyrecky PC; Department of Immunology, University of Toronto, Toronto, ON, Canada.
  • Gower A; Keenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, ON, Canada.
  • Whetstone H; Peter Gilgan Centre for Research and Learning, Hospital for Sick Children, Toronto, ON, Canada.
  • Cahill LS; Mouse Imaging Centre, The Hospital for Sick Children, Toronto, ON, Canada.
  • Ganguly M; Histology Core, The Centre for Phenogenomics, Toronto, ON, Canada.
  • Spring S; Mouse Imaging Centre, The Hospital for Sick Children, Toronto, ON, Canada.
  • Yi TJ; Department of Immunology, University of Toronto, Toronto, ON, Canada.
  • Sled JG; Keenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, ON, Canada.
  • Dunn SE; Mouse Imaging Centre, The Hospital for Sick Children, Toronto, ON, Canada.
Front Immunol ; 12: 570425, 2021.
Article em En | MEDLINE | ID: mdl-33732230
ABSTRACT
Peroxisome proliferator-activated receptor (PPAR)-δ is a nuclear receptor that functions to maintain metabolic homeostasis, regulate cell growth, and limit the development of excessive inflammation during immune responses. Previously, we reported that PPAR-δ-deficient mice develop a more severe clinical course of experimental autoimmune encephalomyelitis (EAE); however, it was difficult to delineate the role that microglia played in this disease phenotype since PPAR-δ-deficient mice exhibited a number of immune defects that enhanced CNS inflammation upstream of microglia activation. Here, we specifically investigated the role of PPAR-δ in microglia during EAE by using mice where excision of a floxed Ppard allele was driven by expression of a tamoxifen (TAM)-inducible CX3C chemokine receptor 1 promoter-Cre recombinase transgene (Cx3cr1CreERT2 Ppardfl/fl). We observed that by 30 days of TAM treatment, Cx3cr1CreERT2 Ppardfl/fl mice exhibited Cre-mediated deletion primarily in microglia and this was accompanied by efficient knockdown of Ppard expression in these cells. Upon induction of EAE, TAM-treated Cx3cr1CreERT2 Ppardfl/fl mice presented with an exacerbated course of disease compared to TAM-treated Ppardfl/fl controls. Histopathological and magnetic resonance (MR) studies on the spinal cord and brains of EAE mice revealed increased Iba-1 immunoreactivity, axonal injury and CNS tissue loss in the TAM-treated Cx3cr1CreERT2 Ppardfl/fl group compared to controls. In early EAE, a time when clinical scores and the infiltration of CD45+ leukocytes was equivalent between Cx3cr1CreERT2 Ppardfl/fl and Ppardfl/fl mice, Ppard-deficient microglia exhibited a more reactive phenotype as evidenced by a shorter maximum process length and lower expression of genes associated with a homeostatic microglia gene signature. In addition, Ppard-deficient microglia exhibited increased expression of genes associated with reactive oxygen species generation, phagocytosis and lipid clearance, M2-activation, and promotion of inflammation. Our results therefore suggest that PPAR-δ has an important role in microglia in limiting bystander tissue damage during neuroinflammation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Axônios / Microglia / PPAR delta / Encefalomielite Autoimune Experimental Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Axônios / Microglia / PPAR delta / Encefalomielite Autoimune Experimental Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá